Clin2
NCT02688517Possibly a fitRecruiting

Tests tumor genomics using blood and stored tissue

Malignant Neoplasm

Part of Cancer clinical trials.

This study looks at the genetic information (DNA) from your blood and from saved tumor tissue to better understand certain cancers, especially rare cancers with a poor outlook. It may help researchers learn why these cancers behave the way they do and guide future treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,100 people
Ages
1 year and older
Study type
Observational

Who can take part

  • You have a cancer diagnosis confirmed by biopsy (tissue sample) and it is rare and/or has a poor prognosis with standard treatment
  • You can take part in clinic visits for surgical, medical, radiation, or imaging (radiology) care
  • Saved tumor tissue is available in paraffin blocks and can be sent for genetic testing
  • Your daily functioning is at least moderate (Karnofsky/Lansky score 30 or higher)
  • Your expected time to live is at least 3 months
  • You sign a written consent form to join the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT01775072Recruiting
Genetic testing using stored or new cancer samples

This study collects and analyzes genetic information from tissue or blood samples to help understand cancer and related inherited (family) risk. It may involve testing results being shared with you or your care team, depending on what samples are available.

Bridgeport, Connecticut
NCT02090530Recruiting
Precision testing of tumor tissue for advanced cancers

This study uses advanced DNA testing on tumor samples to help match cancer treatments more precisely. It may help researchers learn which cancer changes are driving your tumor and how they relate to treatment choices.

Columbus, Ohio
NCT05530759Recruiting
Testing blood and tumor samples for diagnostic cancer markers

This study looks at blood and tumor tissue to find signs (markers) that can help diagnose or better understand metastatic cancer. You may be able to join if you’re getting surgery or a biopsy to remove a tumor and there’s a safe way to collect samples.

Rochester, Minnesota
NCT06606366Recruiting
Genetic tumor testing using a blood test to guide treatment

This study uses a simple blood test to look at the genetic makeup of your tumor. The results may help your doctors choose the best treatment for you. You will need to provide a tumor sample or have a biopsy.

Nice
NCT02474160Recruiting
Banking cancer tissue and blood for future research

This study collects and stores leftover or newly taken samples of tissue and blood from people with cancer. The goal is to build a research library that can help investigators study cancer and develop better tests or treatments.

Birmingham, Alabama
NCT02215928Recruiting
Using tumor genetic tests to guide treatment choices

This study looks at your tumor’s genetic information to help doctors recommend treatment for cancers that have spread. It may help you get the most suitable therapy based on what’s found in your tumor.

Palo Alto, California

Hear when a new Malignant Neoplasm trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.